1. Home
  2. Analysis
  3. Camptosar
  4. Calcium

Camptosar and Calcium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Camptosar (irinotecan hydrochloride) and Calcium (calcium). Common drug interactions include body temperature decreased among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Camptosar and Calcium. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Camptosar?

Camptosar has active ingredients of irinotecan hydrochloride. eHealthMe is studying from 7,145 Camptosar users. Check the latest studies of Camptosar.

What is Calcium?

Calcium has active ingredients of calcium. It is often used in osteoporosis. eHealthMe is studying from 184,201 Calcium users. Check the latest studies of Calcium.

On Jul, 06, 2026

15 people who take Camptosar and Calcium together, and have interactions are studied.

Camptosar and Calcium drug interactions.

What are the common drug interactions of Camptosar and Calcium, by gender? *:

female:

  1. Body temperature decreased
  2. Bradycardia (abnormally slow heart action)
  3. Cardiac disorder
  4. Confusional state
  5. Diplopia (double vision)
  6. Dysphagia (a condition in which swallowing is difficult or painful)
  7. Glioblastoma multiforme (most common and deadliest of malignant primary brain tumours in adults)
  8. Haematocrit
  9. Heart rate decreased
  10. Hypotension (abnormally low blood pressure)

male:

  1. Death
  2. Pyrexia (fever)
  3. Rectal discharge (discharge from rectum)
  4. Stoma site reaction (reaction at abdominal opening)
  5. Blood potassium decreased
  6. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  7. Haematocrit decreased
  8. Haemoglobin decreased
  9. Red blood cell count decreased
  10. Abdominal distension

What are the common drug interactions of Camptosar and Calcium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Blood potassium decreased
  2. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  3. Haematocrit decreased
  4. Haemoglobin decreased
  5. Red blood cell count decreased
  6. Blood creatinine decreased
  7. Blood uric acid decreased
  8. Pneumonitis (inflammation of the walls of the alveoli in the lungs)

20-29:

n/a

30-39:

n/a

40-49:

  1. Scrotal pain
  2. Spinal pain (pain in spine)
  3. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  4. Temperature intolerance (inability to go in temperature)
  5. Testicular pain (pain in testes)
  6. Weight decreased
  7. Pancreatic carcinoma (pancreatic cancer)
  8. Abdominal distension
  9. Abdominal pain
  10. Abdominal pain lower

50-59:

  1. Constipation
  2. Diarrhoea
  3. Fatigue (feeling of tiredness)
  4. Nausea (feeling of having an urge to vomit)
  5. Abdominal discomfort
  6. Abdominal distension
  7. Abdominal pain upper
  8. Arthralgia (joint pain)
  9. Dehydration (dryness resulting from the removal of water)
  10. Dry eye (lack of adequate tears)

60+:

  1. Blood bicarbonate decreased
  2. Cardiac arrest
  3. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  4. Bradycardia (abnormally slow heart action)
  5. Cardiac disorder
  6. Fatigue (feeling of tiredness)
  7. Hypotension (abnormally low blood pressure)
  8. Hypotonia (low muscle tone)
  9. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  10. Malaise (a feeling of general discomfort or uneasiness)

What are the existing conditions these people have? *

  1. Tumor: 2 people, 13.33%
  2. Small Cell Lung Cancer Stage Unspecified (lung cancer in unknown stage): 2 people, 13.33%
  3. Rectal Cancer (cancer of rectum): 2 people, 13.33%
  4. Colon Cancer Metastatic (cancer of colon spreads to other part of body): 2 people, 13.33%
  5. Colon Cancer: 2 people, 13.33%
  6. Pancreatic Carcinoma (pancreatic cancer): 1 person, 6.67%
  7. Pain: 1 person, 6.67%
  8. Nausea (feeling of having an urge to vomit): 1 person, 6.67%
  9. Depression: 1 person, 6.67%
  10. Brain Neoplasm Malignant (brain cancer tumour): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Camptosar and Calcium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Camptosar and Calcium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Camptosar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Calcium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Camptosar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Calcium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on irinotecan hydrochloride and calcium (the active ingredients of Camptosar and Calcium, respectively), and Camptosar and Calcium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.